Various therapies such as PARP inhibitors, anti-androgen therapy, PI3K inhibitors, MEK inhibitors, inhibitors of the cancer stem-cell population, EGFR inhibitors and HDAC inhibitors have been explored to cure TNBC patients because of the lack of specific TNBC therapies. This evidence concerns the gene HDAC9 and cancer.